Secondary analysis of the 2021–2023 Sepsis Epidemiology in Australian and New Zealand Children Observational Dataset: Association Between Presenting Venous Lactate Concentration and 72-Hour Outcomes

{"OBJECTIVES:":[0],"In":[1,115,263],"pediatric":[2],"patients":[3],"with":[4,17,70,118,153,282,301],"sepsis,":[5,285],"we":[6,272],"hypothesized":[7],"that":[8,275],"the":[9,38,75,89,215,234,251,268,277],"initial":[10,90,149,287],"venous":[11,91,288],"lactate":[12,92,150,189,241,289],"concentration":[13,93,151,242],"would":[14],"be":[15],"associated":[16,152],"subsequent":[18,106,302],"need":[19,107,303,313],"for":[20,105,108,224,304],"extracorporeal":[21],"life":[22],"support":[23],"(ECLS)":[24],"or":[25,110,142,155,179,192,226,245,292,306],"death":[26,111,156,227],"within":[27,95,112,144,157,182,228,308],"72":[28,113,145,158,183,229,309],"hours.":[29,114,146,184,310],"DESIGN:":[30],"A":[31],"planned":[32],"secondary":[33,265],"analysis":[34,266],"of":[35,63,98,125,168,174,201,207,219,256,267],"data":[36],"from":[37,258],"multicenter,":[39],"two-country":[40],"Sepsis":[41],"Epidemiology":[42],"Emergency":[43],"Departments":[44],"(SENTINEL)":[45],"study,":[46],"collected":[47],"2021-2023.":[48],"SETTING:":[49],"Acute":[50],"care":[51],"hospitals":[52],"in":[53,166,233,324],"Australia":[54],"and":[55,136,163,212],"New":[56],"Zealand.":[57],"PATIENTS:":[58],"SENTINEL":[59,270],"participants":[60],"were":[61,134],"children":[62,132,138,170,176,279],"0":[64],"to":[65,74,194,247,253,260,294,314],"less":[66],"than":[67,191,244,291],"18":[68],"years":[69,127],"suspected":[71,283],"sepsis":[72],"admitted":[73],"hospital":[76,99],"through":[77],"11":[78],"emergency":[79],"departments.":[80],"INTERVENTIONS:":[81],"None.":[82],"MEASUREMENTS":[83],"AND":[84],"MAIN":[85],"RESULTS:":[86],"We":[87],"used":[88],"(sampling":[94],"4":[96],"hr":[97],"arrival)":[100],"as":[101],"an":[102,286,298],"explanatory":[103],"variable":[104],"ECLS":[109,141,154,178,225],"4806":[116,169],"children,":[117],"a":[119,186,239],"median":[120],"(interquartile":[121],"range":[122],"[IQR])":[123],"age":[124],"1.9":[126],"(IQR,":[128],"0.2-6.7":[129],"yr),":[130],"2651":[131],"(55.2%)":[133],"males,":[135],"33":[137,175],"(0.7%)":[139],"received":[140],"died":[143,181],"The":[147],"best-performing":[148],"hours":[159],"was":[160,164],"3.5":[161,195,248,295],"mmol/L":[162,196,249,296],"observed":[165],"745":[167],"(15.5%),":[171],"including":[172],"24":[173],"requiring":[177],"who":[180],"As":[185],"\\"diagnostic\\"":[187],"test,":[188],"greater":[190,243,290],"equal":[193,246,293],"had":[197],"sensitivity":[198],"(95%":[199,203,209,221],"CI)":[200],"72.7%":[202],"CI,":[204,210,222],"54.5-86.7%),":[205],"specificity":[206],"84.9%":[208],"83.9-85.9%),":[211],"area":[213],"under":[214],"receiver-operating":[216],"characteristics":[217],"curve":[218],"0.79":[220],"0.71-0.87)":[223],"hours,":[230],"which":[231],"are":[232,280],"acceptable-to-fair":[235,299],"category.":[236],"That":[237],"is,":[238],"4-hour":[240],"takes":[250],"pre-":[252],"posttest":[254],"probability":[255],"ECLS/death":[257],"0.7%":[259],"3.2%.":[261],"CONCLUSIONS:":[262],"this":[264],"2021-2023":[269],"dataset,":[271],"have":[273],"found":[274],"at":[276],"time":[278],"hospitalized":[281],"community-acquired":[284],"has":[297],"association":[300],"ECLS,":[305],"death,":[307],"Clinicians":[311],"will":[312],"decide":[315],"whether":[316],"such":[317],"testing":[318],"on":[319],"its":[320],"own":[321],"is":[322],"useful":[323],"decision-making.":[325]}